More than half of the people living with HIV in Philadelphia are 50 and older, and they face greater risk of frailty and impairment.

A successful blood borne virus (BBV) opt-out testing programme is being expanded across NHS Greater Manchester emergency ...

Indaptus Therapeutics (INDP) has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use ...

Fourth quarter and full year 2024 BRIUMVI U.S. net revenue of $103.6 million and $310 million, respectivelyTarget guidance of approximately $540 ...

Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps ...

Q4 2024 Earnings Call Transcript February 26, 2025 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is ...

Viral infections are a predominant cause of liver disease around the world, impacting millions with conditions ranging from mild inflammation to severe ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...

In this piece, we include reporting tips, how vaccine side effects are tracked in the U.S., and what research shows about the ...

To facilitate the achieving of the goal of “eliminating viral hepatitis as a major public health threat by 2030” set by the World Health Organization, the Chinese Society of Hepatology together with ...

Adolescents who are treatment-naive had promising results when using dolutegravir/lamivudine as antiretroviral therapy over ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...